F. Xu

发表

Over-expression of RPL23 in myelodysplastic syndromes is associated with apoptosis resistance of CD34+ cells and predicts poor prognosis and distinct response to CHG chemotherapy or decitabine

Yan Zhang, Xiao Li, Chun-kang Chang, 2012, Annals of Hematology.

Dynamics of epigenetic regulator gene BCOR mutation and response predictive value for hypomethylating agents in patients with myelodysplastic syndrome

Xiao Li, Chun-kang Chang, Juan Guo, 2021, Clinical Epigenetics.

Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromes.

Xiao Li, Chun-kang Chang, Juan Guo, 2017, American journal of translational research.

Somatic mutations in SF3B1 aberrant‐negative MDS‐RS most commonly involved in TP53 genes

Xiao Li, Juan Guo, Lingyun Wu, 2022, Journal of cellular and molecular medicine.

Low RPS14 expression in MDS without 5q ‐ aberration confers higher apoptosis rate of nucleated erythrocytes and predicts prolonged survival and possible response to lenalidomide in lower risk non‐5q‐ patients

Xiao Li, Chun-kang Chang, Lingyun Wu, 2013, European journal of haematology.

Immunophenotypic analysis of erythroid dysplasia and its diagnostic application in myelodysplastic syndromes

Zhaoxiang Zhang, F. Xu, Q. He, 2012, Internal medicine journal.

Flow cytometric scoring system (FCMSS) assisted diagnosis of myelodysplastic syndromes (MDS) and the biological significance of FCMSS‐based immunophenotypes

Xiao Li, Chun-kang Chang, Lingyun Wu, 2010, British journal of haematology.

Interleukin‐17 enhances the production of interferon‐γ and tumour necrosis factor‐α by bone marrow T lymphocytes from patients with lower risk myelodysplastic syndromes

Yan Zhang, Xiao Li, Chun-kang Chang, 2013, European journal of haematology.

Diagnostic application and clinical significance of FCM progress scoring system based on immunophenotyping in CD34+ blasts in myelodysplastic syndromes

Xiao Li, Chun-kang Chang, Juan Guo, 2013, Cytometry. Part B, Clinical cytometry.

Distinct Clinical and Experimental Characteristics in the Patients Younger than 60 Years Old with Myelodysplastic Syndromes

Z. Xiao, Xiao Li, Chun-kang Chang, 2013, PloS one.

Overexpression of BMI1 confers clonal cells resistance to apoptosis and contributes to adverse prognosis in myelodysplastic syndrome.

Xiao Li, Chun-kang Chang, Juan Guo, 2012, Cancer letters.

TP53 mutations predict decitabine‐induced complete responses in patients with myelodysplastic syndromes

Xiao Li, Chun-kang Chang, Juan Guo, 2017, British journal of haematology.

Comparison of immunological abnormalities of lymphocytes in bone marrow in myelodysplastic syndrome (MDS) and aplastic anemia (AA).

Xiao Li, Chun-kang Chang, Lingyun Wu, 2010, Internal medicine.

A delayed yet durable response to very short lenalidomide therapy and unexpected clone redistribution in a case of myelodysplastic syndrome with del(5q) and del(20q).

Xiao Li, Chun-kang Chang, Lingyun Wu, 2009, Leukemia research.

Genomic loss of EZH2 leads to epigenetic modifications and overexpression of the HOX gene clusters in myelodysplastic syndrome

Yang Zhu, Xiao Li, Chun-kang Chang, 2016, Oncotarget.

Somatic mutations of activating signalling, transcription factor, and tumour suppressor are a precondition for leukaemia transformation in myelodysplastic syndromes

Xiao Li, Juan Guo, Lingyun Wu, 2022, Journal of cellular and molecular medicine.

Ribosomal protein L23 negatively regulates cellular apoptosis via the RPL23/Miz-1/c-Myc circuit in higher-risk myelodysplastic syndrome

Xiao Li, Chun-kang Chang, Lingyun Wu, 2017, Scientific Reports.

Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes

Yang Zhu, Xiao Li, Chun-kang Chang, 2015, Nature Communications.

The role of histone methyltransferase EZH2 in myelodysplastic syndromes

Xiao Li, F. Xu, 2012, Expert review of hematology.

MYCN contributes to the malignant characteristics of erythroleukemia through EZH2-mediated epigenetic repression of p21

Xiao Li, Chun-kang Chang, Li Liu, 2017, Cell Death & Disease.

Somatic mutations of activated signaling genes, transcription factors, or tumor suppressors are a precondition for leukemic transformation from myelodysplastic syndromes: a sequencing analysis of 64 paired samples

Xiao Li, Chun-kang Chang, Feng Xu, 2021, bioRxiv.

Tumor suppressor gene BLU is frequently downregulated by promoter hypermethylation in myelodysplastic syndrome

Xiao Li, Lingyun Wu, F. Xu, 2012, Journal of Cancer Research and Clinical Oncology.

Genetic landscape of recurrent ASXL1, U2AF1, SF3B1, SRSF2, and EZH2 mutations in 304 Chinese patients with myelodysplastic syndromes

Saijuan Chen, Lanping Xu, Xiao Li, 2016, Tumor Biology.

Identification of microRNA-regulated pathways using an integration of microRNA-mRNA microarray and bioinformatics analysis in CD34+ cells of myelodysplastic syndromes

Yang Zhu, Xiao Li, Chun-kang Chang, 2016, Scientific Reports.

IGF-IR promotes clonal cell proliferation in myelodysplastic syndromes via inhibition of the MAPK pathway

Sida Zhao, Xiao Li, Chun-kang Chang, 2020, Oncology reports.

Interleukin-17-producing CD4+ T lymphocytes are increased in patients with primary immune thrombocytopenia

Xiao Li, Chun-kang Chang, Y. Tao, 2016, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Ribosomal protein L23 negatively regulates cellular apoptosis via the RPL23/Miz-1/c-Myc circuit in higher-risk myelodysplastic syndrome

Xiao Li, Chun-kang Chang, Lingyun Wu, 2017, Scientific Reports.

Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring

Xiao Li, Chun-kang Chang, Lingyun Wu, 2011, Annals of Hematology.

Establishment and Validation of an Updated Diagnostic FCM Scoring System Based on Pooled Immunophenotyping in CD34+ Blasts and Its Clinical Significance for Myelodysplastic Syndromes

Yang Zhu, Xiao Li, Chun-kang Chang, 2014, PloS one.

Cytogenetic response based on revised IPSS cytogenetic risk stratification and minimal residual disease monitoring by FISH in MDS patients treated with low-dose decitabine.

Xiao Li, Chun-kang Chang, Lingyun Wu, 2013, Leukemia research.

The efficacy and toxicity of the CHG priming regimen (low-dose cytarabine, homoharringtonine, and G-CSF) in higher risk MDS patients relapsed or refractory to decitabine

Xiao Li, Chun-kang Chang, Y. Tao, 2019, Journal of Cancer Research and Clinical Oncology.

Decitabine of Reduced Dosage in Chinese Patients with Myelodysplastic Syndrome: A Retrospective Analysis

Q. Song, M. Hou, Xiao Li, 2014, PloS one.

Cytogenetic Response Based On Revised IPSS Cytogenetic Risk Stratification and Minimal Residual Disease Monitoringby FISH In MDS Patients Treated By Low-Dose Decitabine

Chun-kang Chang, Lingyun Wu, Dong-dong Wu, 2013 .

The biological behavior of SDF-1/CXCR4 in patients with myelodysplastic syndrome

Xiao Li, Chun-kang Chang, Feng Xu, 2012, Medical Oncology.

Transcriptional regulation of miR-10a/b by TWIST-1 in myelodysplastic syndromes

H. Deeg, Xiang Li, T. Papayannopoulou, 2013, Haematologica.

Rigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways in high-grade myelodysplastic syndrome

Ling Wu, Yang Zhu, Xiao Li, 2014, Scientific Reports.

High expression of the human equilibrative nucleoside transporter 1 gene predicts a good response to decitabine in patients with myelodysplastic syndrome

Xiao Li, Chun-kang Chang, Wenhui Shi, 2016, Journal of Translational Medicine.

U2AF1 mutation promotes tumorigenicity through facilitating autophagy flux mediated by FOXO3a activation in myelodysplastic syndromes

Yuqian Zhu, Xiao Li, Chun-kang Chang, 2021, Cell Death & Disease.

A genetic development route analysis on MDS subset carrying initial epigenetic gene mutations

Xiao Li, Chun-kang Chang, Feng Xu, 2020, Scientific Reports.

Increased PD-1/STAT1 ratio may account for the survival benefit in decitabine therapy for lower risk myelodysplastic syndrome

Xiao Li, Chun-kang Chang, Juan Guo, 2017, Leukemia & lymphoma.

Purification of Bone Marrow Clonal Cells from Patients with Myelodysplastic Syndrome via IGF-IR

Xiao Li, Chun-kang Chang, Wenhui Shi, 2015, PloS one.

SF3B1-mutated myelodysplastic syndrome with ring sideroblasts harbors more severe iron overload and corresponding over-erythropoiesis.

Yang Zhu, Xiao Li, Chun-kang Chang, 2016, Leukemia research.

Overexpression of IGF-IR in Malignant Clonal Cells in Bone Marrow of Myelodysplastic Syndromes

Xiao Li, Y. Tao, Yi-zhi Liu, 2010, Cancer investigation.

A genetic development route analysis on MDS subset carrying initial epigenetic gene mutations

Xiao Li, Chun-kang Chang, Juan Guo, 2020, Scientific Reports.

Exploration of the role of gene mutations in myelodysplastic syndromes through a sequencing design involving a small number of target genes

Xiao Li, Chun-kang Chang, Feng Xu, 2017, Scientific Reports.

DHX9-mediated pathway contributes to the malignant phenotype of myelodysplastic syndromes

Xiao Li, Juan Guo, Wenhui Shi, 2023, iScience.

Down-regulation of Dicer1 promotes cellular senescence and decreases the differentiation and stem cell-supporting capacities of mesenchymal stromal cells in patients with myelodysplastic syndrome

Yang Zhu, Xiao Li, Chun-kang Chang, 2015, Haematologica.

Updated insights on cardiac risks of CD19-directed chimeric antigen receptor T-cell therapy: a pharmacovigilance study.

Jin-fang Xu, X. Ye, F. Hu, 2023, Immunotherapy.

The Evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes

Xiao Li, Chun-kang Chang, Juan Guo, 2013, Hematology.

Aberrant promoter methylation of Dab2 gene in myelodysplastic syndrome

Xiao Li, Chun-kang Chang, F. Xu, 2012, European journal of haematology.

High expression of the human equilibrative nucleoside transporter 1 gene predicts a good response to decitabine in patients with myelodysplastic syndrome

Qi He, Feng Xu, Lingyun Wu, 2016, Journal of Translational Medicine.

Efficacy and toxicity of decitabine versus CHG regimen (low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor) in patients with higher risk myelodysplastic syndrome: a retrospective study

Xiao Li, Chun-kang Chang, Lingyun Wu, 2016, Leukemia & lymphoma.

Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes

Yang Zhu, Xiao Li, Chun-kang Chang, 2015, Nature Communications.

ROBO1 deficiency impairs HSPC homeostasis and erythropoiesis via CDC42 and predicts poor prognosis in MDS.

Cheng-Long Hu, Juan Guo, Lingyun Wu, 2023, Science Advances.

NPM1 mutation with DNMT3A wild type defines a subgroup of MDS with particularly favourable outcomes after decitabine therapy

Xiao Li, Chun-kang Chang, Juan Guo, 2020, British Journal of Haematology.

High expression of APAF-1 elevates erythroid apoptosis in iron overload myelodysplastic syndrome

Xiao Li, Chun-kang Chang, Feng Xu, 2013, Tumor Biology.